How To Be Prepared For A Catastrophic Data Breach

Pharmaceutical companies will be directly affected by the EU’s General Data Protection Regulation because they often hold large amounts of personal health information, such as clinical trial data, and any accidental disclosure of those data will be taken very seriously by the regulatory authorities. Richard Dickinson, Jacqueline Mulryne and Zoe Walkinshaw look at what companies should be doing to limit the impact of a catastrophic data breach on their corporate reputation, the individuals affected, and the validity of the data.

DataBreach
Pharma firms need to know how to deal with a data breach • Source: Shutterstock

The EU privacy landscape underwent a seismic shift in May 2018 when the General Data Protection Regulation (GDPR) was introduced. In the post-GDPR world, all companies face tougher fines if they experience a personal data breach – up to €20m or 4% of worldwide annual turnover.

About the Authors

Richard Dickinson and Jacqueline Mulryne are partners, and Zoe Walkinshaw is an associate, at law firm Arnold & Porter.

There are also tougher obligations to report breaches, in particular those that pose a risk to people’s rights and freedoms....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography